Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force von Stauder, R., Eichhorst, B., Hamaker, M.E., Kaplanov, K., Morrison, V.A., Österborg, A., Poddubnaya, I., Woyach, J.A., Shanafelt, T., Smolej, L., Ysebaert, L., Goede, V.

Volltext

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells von Daneshmanesh, A H, Hojjat-Farsangi, M, Khan, A S, Jeddi-Tehrani, M, Akhondi, M M, Bayat, A A, Ghods, R, Mahmoudi, A-R, Hadavi, R, Österborg, A, Shokri, F, Rabbani, H, Mellstedt, H

Volltext

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia von Ludwig, Heinz, Aapro, M., Bokemeyer, C., Glaspy, J., Hedenus, M., Littlewood, T.J., Österborg, A., Rzychon, B., Mitchell, D., Beguin, Y.

Volltext

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia von Österborg, A, Foà, R, Bezares, R F, Dearden, C, Dyer, M J S, Geisler, C, Lin, T S, Montillo, M, van Oers, M H J, Wendtner, C-M, Rai, K R

Volltext

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron von Aapro, M., Österborg, A., Gascón, P., Ludwig, H., Beguin, Y.

Volltext

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome von Lundin, Jeanette, Hagberg, Hans, Repp, Roland, Cavallin-Ståhl, Eva, Fredén, Susanne, Juliusson, Gunnar, Rosenblad, Eija, Tjønnfjord, Geir, Wiklund, Tom, Österborg, Anders

Volltext

Targets for Ibrutinib Beyond B Cell Malignancies von Berglöf, A., Hamasy, A., Meinke, S., Palma, M., Krstic, A., Månsson, R., Kimby, E., Österborg, A., Smith, C. I. E.

Volltext

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study von Rieger, M., Österborg, A., Pettengell, R., White, D., Gill, D., Walewski, J., Kuhnt, E., Loeffler, M., Pfreundschuh, M., Ho, A.D.

Volltext

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines von Aapro, M, Beguin, Y, Bokemeyer, C, Dicato, M, Gascón, P, Glaspy, J, Hofmann, A, Link, H, Littlewood, T, Ludwig, H, Österborg, A, Pronzato, P, Santini, V, Schrijvers, D, Stauder, R, Jordan, K, Herrstedt, J

Volltext

Too-low iron doses and too many dropouts in negative iron trial? von Aapro, Matti, Beguin, Yves, Birgegård, Gunnar, Gascón, Pere, Hedenus, Michael, Osterborg, Anders

Volltext

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update von Bokemeyer, C, Aapro, M.S, Courdi, A, Foubert, J, Link, H, Österborg, A, Repetto, L, Soubeyran, P

Volltext

Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study von Österborg, Anders, Brandberg, Yvonne, Hedenus, Michael

Volltext

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant von Gao, Yu, Cai, Curtis, Grifoni, Alba, Müller, Thomas R., Niessl, Julia, Olofsson, Anna, Humbert, Marion, Hansson, Lotta, Österborg, Anders, Bergman, Peter, Chen, Puran, Olsson, Annika, Sandberg, Johan K., Weiskopf, Daniela, Price, David A., Ljunggren, Hans-Gustaf, Karlsson, Annika C., Sette, Alessandro, Aleman, Soo, Buggert, Marcus

Volltext

Complement-dependent cytotoxicity exerted by two therapeutic anti-CD20 mAbs: Rituximab and ofatumumab in human B-cell malignant cell lines and primary cultures von Okroj, M., Eriksson, I., Österborg, A., Blom, A.

Volltext

First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor von Mellstedt, H., Hojjat-Farsangi, M., Daneshmanesh, A.H., Moshfegh, A., Byström, S., Norin, M., Olin, T., Schultz, J., Vågberg, J., Österborg, A.

Volltext

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies : a rando... von HEDENUS, M, BIRGEGARD, G, NÄSMAN, P, AHLBERG, L, KARLSSON, T, LAURI, B, LUNDIN, J, LÄRFARS, G, ÖSTERBORG, A

Volltext

Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation von Karlsson, C, Norin, S, Kimby, E, Sander, B, Porwit MacDonald, A, Nilsson, B, Johansson, E, Mellstedt, H, Lundin, J, Österborg, A

Volltext

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells von Hojjat-Farsangi, M., Daneshmanesh, A. H., Khan, A. S., Shetye, J., Mozaffari, F., Kharaziha, P., Rathje, L.-S., Kokhaei, P., Hansson, L., Vågberg, J., Byström, S., Olsson, E., Löfberg, C., Norström, C., Schultz, J., Norin, M., Olin, T., Österborg, A., Mellstedt, H., Moshfegh, A.

Volltext

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial von Tam, Constantine S, Brown, Jennifer R, Kahl, Brad S, Ghia, Paolo, Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Shadman, Mazyar, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M, Flinn, Ian W, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C, Cohen, Aileen, Huang, Jane, Robak, Tadeusz, Hillmen, Peter

Volltext

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia von Brown, Jennifer R., Eichhorst, Barbara, Hillmen, Peter, Jurczak, Wojciech, Kaźmierczak, Maciej, Lamanna, Nicole, O’Brien, Susan M., Tam, Constantine S., Qiu, Lugui, Zhou, Keshu, Simkovic, Martin, Mayer, Jiri, Gillespie-Twardy, Amanda, Ferrajoli, Alessandra, Ganly, Peter S., Weinkove, Robert, Grosicki, Sebastian, Mital, Andrzej, Robak, Tadeusz, Osterborg, Anders, Yimer, Habte A., Salmi, Tommi, Wang, Megan-Der-Yu, Fu, Lina, Li, Jessica, Wu, Kenneth, Cohen, Aileen, Shadman, Mazyar

Volltext